StockWatch
·

CSM Technologies Ltd Q4 FY26 Results

CSMQ4 FY26 Results
Filing
MetricValueChange
Revenue60.43 Cr
Total Income61.67 Cr
Expenditure47.50 Cr
PBT11.44 Cr
Net Profit9.30 Cr
OPM
NPM15.08%
EPS2.41
View full financials
CSM TECHNOLOGIES · Q4 FY26 · THE VERDICT

Strong Margins, Drowning in Receivables

Reported 15.1% PAT margin and ₹357.6 Cr order book mask a working capital crisis: days sales outstanding spiked 122% to 129 days, and revenue contracted 6.25% quarter-on-quarter. The stock's own post-result fade tells the real story.

02 Aug 2026 · 6 min read
Reported Q4 PAT

₹9.3 Cr

15.1% margin vs 8.7% prior year

Q4 Revenue (QoQ)

₹60.4 Cr

−6.25% from ₹64 Cr (Q3)

Days sales outstanding

129 days

+122% from 58 days

Order book visibility

₹357.6 Cr

3–5 year contracts, 2+ years forward

On the surface, CSM Technologies reported a profitable quarter: 15.1% net profit margin, 26.6% EBITDA margin, and a solid ₹357.6 crore order book with multi-year visibility. But dig into the working capital and the story inverts. Days sales outstanding exploded 122% to 129 days in a single quarter, revenue contracted quarter-on-quarter for the first time on record, and 60% of revenue is concentrated in one state. The profit expansion is real but built on cost discipline in a shrinking revenue quarter—and the cash is stuck with government counterparties. The stock's own post-result price action reflects this ambiguity: a +3.86% pop on day 1 faded to −0.7% by day 5.

Reconcile the reported profit

Q4 reported PAT of ₹9.3 Cr reflects a one-time ₹2.7 crore charge for compliance with new labor codes. Excluding this exceptional item, normalized Q4 profit was approximately ₹12 Cr—still showing the working capital strain but without the compliance headwind. The margin expansion to 15.1% (from 8.7% in Q4 FY25) is real, but the driver is 'disciplined cost management,' not pricing power or volume leverage. EBITDA margin jumped to 26.6% from 17.5% prior year, but this is in a quarter where revenue fell 6.25% sequentially.

Q4 FY26 Profitability, ₹ Cr
04.488.9613.449.3Reported PAT2.7Labor code charge12Normalized PAT
Exceptional labor code charge inflates the reported profit decline versus underlying run-rate.

Where this profit came from

The margin story is cost discipline, not growth. EBITDA margin expanded 9.1 percentage points year-on-year to 26.6%, while revenue moderated 6.25% sequentially and the order book (₹357.6 Cr) remains the only forward-revenue anchor. Management attributed the QoQ revenue dip to seasonal government budget cycles—Q1–Q2 are historically slow, Q3–Q4 accelerate—and cited 'exceptional' strength in Q4 prior year as the comparison bar. That may be true, but it signals execution volatility rather than stable run-rate expansion.

Management's claims vs. what the numbers show

CSM's on-call narrative graded against the delivered result

EBITDA margin expanded to 26.6% in Q4 vs 17.5% prior year

Verified. But driven by cost discipline in a revenue-declining quarter (Q3 ₹64 Cr → Q4 ₹60.4 Cr). No pricing power or volume leverage evident.

Supported but context-dependent

Order book ₹357.6 Cr provides 2+ years' execution visibility with 3–5 year contracts

Corroborated on call and consistent with stated contract terms. Execution pace unverified; depends on Q1–Q2 booking ramp.

Supported

Geographic concentration improving; recent wins in Adani (Assam), Kenya, Ethiopia show diversification

Recent deal wins confirmed (Q4 bookings). But international revenue is only 5% of FY26 total; Odisha still 60%. Diversification is aspirational, not yet at scale.

Slightly overstated

DSO spiked due to normal government approval delays; management has mastered aligning liquidity to this pattern

DSO jumped 122% from 58 to 129 days. Government payment lag acknowledged but no remediation timeline or corrective action plan disclosed. Suggests acceptance rather than active resolution.

Acknowledged but downplayed risk

International revenue growing at larger pace; will reflect better numbers this year due to recent deal bookings

International revenue was 5% of FY26 (export 9%). Recent bookings (Kenya fish chain, Ethiopia market linkage) are early-stage. No quantification of expected international ramp.

Aspirational

What changed on this call

Revenue momentum shifted: Q3 FY26 ₹64 Cr → Q4 ₹60.4 Cr (−6.25% QoQ). Management normalized this as seasonal govt. cyclicality but it signals execution slowdown or deal ramp uncertainty. Working capital deteriorated sharply: DSO jumped from 58 days to 129 days (+122%), driven by government approval delays in Odisha (60% of revenue). Management attributed it to normal govt lag but offered no timeline for correction. Geographic expansion moves announced: Adani (Assam), Khanij 2.0 (Chhattisgarh), NAFED (Pan-India), Kenya fish chain, Ethiopia digital market. Diversification is underway but early-stage. Forward guidance stayed vague: First earnings call; management declined to quantify FY27 revenue or order bookings, citing 'higher side' and 'better than last year' only. Unusual for a newly listed entity.

The bull-bear ledger

Reasons to own vs. reasons to sell
  • Order book of ₹357.6 Cr provides multi-year, visible revenue stream

  • Repeat customer base 90–95% (15–20 year relationships) signals execution quality

  • Government digitalization spend is a structural tailwind (India + Africa)

  • First-mover in Africa GovTech with 14-country footprint

  • Q4 revenue declined 6.25% QoQ despite order book strength—execution risk visible

  • DSO at 129 days (from 58) means cash is locked up for 4+ months with government

  • 60% Odisha concentration + 129-day payment cycle = dual working capital risk

  • International revenue only 5%; diversification unproven at scale

  • No forward guidance quantified; first listed earnings call atypical in disclosure

Ranked risks for a holder

What should concern an investor, ordered by severity

Working capital spiral: DSO at 129 days with ₹60.4 Cr quarterly revenue

High

Cash collected 4+ months after billing. Odisha government (60% of revenue) is the payment source; no timeline for normalization offered. If DSO stays elevated, free cash flow becomes negative despite reported profit.

Geographic & customer concentration: 60% Odisha, mining (i3MS) is largest vertical

High

Concentration of payment risk (DSO spike) + revenue risk (one state, one sector). Regulatory shift in Odisha mining or policy change could hollow revenue. Diversification efforts (Assam, Kenya, Ethiopia) are early-stage.

Revenue execution volatility: Q3 ₹64 Cr → Q4 ₹60.4 Cr despite ₹357.6 Cr order book

Medium

Order book is large but drawdown pace is uneven. Government budget cycles (Q1–Q2 slow, Q3–Q4 accelerate) add volatility. Execution risk caps visibility.

Regulatory & compliance headwinds: ₹2.7 Cr labor code charge in Q4

Medium

One-time charge but signals future compliance cost exposure. With ~1,300 employees and government as primary client, regulatory shifts (wage laws, benefits mandates) could recur and compress margins.

AI positioning unquantified: aspirational messaging without order book proof

Low

Management extensively discussed AI use cases (land approval, exams, LLM training on govt data) but could not quantify % of order book or expected ramp. If competition enters GovTech with AI, CSM's differentiation may blur.

How the street is positioned

The stock was announced at ₹99.7. It popped +3.86% on day 1 (initial relief—results aligned with expectations, order book intact), but by day 3 it was down 2.71%, and by day 5 it had faded to −0.7%. This fade is the market's own verdict: the margin narrative doesn't survive scrutiny when you factor in 129-day receivables, 60% Odisha concentration, and no forward guidance. The stock is currently trading at ₹104.4, still down 6.95% from its all-time high of ₹112.2 but up 11% from its 52-week low of ₹94. RSI at 56.6 is neutral. On Jul 29, there was a bulk sell of 3,00,000 shares at ₹96.60—profit-taking by an unnamed seller—below where the stock recovered to post-result. This suggests insiders or informed traders saw the reversion risk and cashed in.

Valuation context: CSM trades near its 52-week midpoint, having given back most of its post-announcement gains. The market is repricing the quarter from 'margin expansion story' to 'execution and cash-flow story.' Until DSO normalizes and diversification proves out, the stock will likely remain range-bound.

The debate

What to watch next

Three concrete milestones to resolve the debate
  • 1 · FY27 Q1–Q2 order bookings and deal execution

    Management expects revenue upside for FY27 tied to Q1–Q2 deal bookings. Watch for: (a) order book growth (from current ₹357.6 Cr), (b) geographic breadth (Assam, Rajasthan, international wins as % of total), (c) execution pace into Q3–Q4. If the order book shrinks or Q1–Q2 deals disappoint, the FY27 guidance ('higher side,' 'upside') evaporates.

  • 2 · DSO normalization by Q1–Q2 FY27

    Government digitalization is supposed to improve payment cycles. Watch for DSO to trend back toward 60–75 days by Q2 FY27. If DSO stays at 120+ days, the cash-flow story is broken and capex becomes constrained. This is THE number to track.

  • 3 · International revenue ramp and new-state contribution

    By Q2–Q3 FY27, watch for: (a) international revenue to exceed 10% of quarterly run-rate (vs 5% of FY26 total), (b) new-state revenue (Assam, Rajasthan, Chhattisgarh, pan-India NAFED) to visibly reduce Odisha % below 50%. These are the proof-points for diversification.

CSM Technologies is a solid GovTech franchise with order-book visibility, a strong repeat-customer base, and exposure to structural tailwinds in government digitalization. But this quarter revealed a sharp working-capital crisis: DSO spiked 122% to 129 days, revenue moderated quarter-on-quarter, and 60% of revenue is locked in a single state whose payment cycles are stretching cash collection cycles to 4+ months. The reported profit looks strong (15.1% margin, 26.6% EBITDA) because cost discipline is real, but it masks the cash-flow reality.

The order book of ₹357.6 Cr is the company's main asset. If CSM can execute it while diversifying away from Odisha and normalizing DSO, it will compound sustainably. But execution risk is high, and the market's own price action (fade from day 1 pop to −0.7% by day 5) suggests skepticism. The stock is a Hold for current holders—own it for the long-term order-book visibility and government tailwind, but demand proof of DSO normalization and geographic diversification before getting aggressive. The single number to track from here is DSO: if it doesn't improve to 75 days by Q2 FY27, the franchise story cracks.

Informational and educational content only. Not investment advice.